HealthDay News — Use of a ceramide-infused ostomy skin barrier is associated with reduced stoma-related cost of care, according to a study published in the Journal of Wound, Ostomy and Continence Nursing.

Janice C. Colwell, RN, from the University of Chicago Medicine, and colleagues conducted a multicentered international trial involving 153 adults from 25 sites in the United States, Canada, and Europe. Ostomy-related costs were examined and the incidence of peristomal skin complications (PSCs) was compared for ceramide-infused ostomy skin barriers and control skin barriers.

The researchers found that over a 12-week period there was a significant reduction in stoma-related cost of care with use of the ceramide-infused barrier, resulting in a 14% relative decrease in cost (reduction of $36.46). 

Continue Reading

The adjusted average costs were $223.73 and $260.19 in the treatment and control groups, respectively (P =.017). The overall incidence of PSC was 47.7%; 40.5% and 55.4% for the control and treatment groups, respectively (P =.069; 95% CI, −1.2 to 30.4).

In the ceramide-infused skin barrier group, significantly more participants were very satisfied with barrier performance, prevention of leakage, and prevention of itching. Both groups had general postoperative improvement in health-related quality of life.

“The use of a ceramide-infused barrier significantly decreased cost and increased satisfaction with patient-reported outcomes,” the authors write.

Several authors disclosed financial ties to medical product companies, including Hollister Incorporated, which funded the study.

Related Articles


Colwell JC, Pittman J, Raizman R, Salvadalena G. A randomized controlled trial determining variances in ostomy skin conditions and the economic impact (ADVOCATE trial). J Wound Ostomy Continence Nurs. 2018; 45(1):37-42.